Case Report
Effective Administration of Rituximab in Anti-MDA5 Antibody–Positive Dermatomyositis with Rapidly Progressive Interstitial Lung Disease and Refractory Cutaneous Involvement: A Case Report and Literature Review
Figure 3
Chest computed tomography findings at admission (a), before the addition of rituximab (RTX) (b), and after RTX administration (c).
(a) |
(b) |
(c) |